GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » Sale Of Investment

Sunflower Pharmaceutical Group Co (SZSE:002737) Sale Of Investment : ¥3,073 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co Sale Of Investment?

Sunflower Pharmaceutical Group Co's sale of investment for the three months ended in Mar. 2024 was ¥1,021 Mil. It means Sunflower Pharmaceutical Group Co gained ¥1,021 Mil from selling investments. Sunflower Pharmaceutical Group Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,073 Mil.

Compared with last quarter (¥607 Mil in Dec. 2023 ), Sunflower Pharmaceutical Group Co gained more money from selling investments in Mar. 2024 (¥1,021 Mil).


Sunflower Pharmaceutical Group Co Sale Of Investment Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co Sale Of Investment Chart

Sunflower Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 559.58 665.21 1,213.12 2,193.50 2,303.61

Sunflower Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.78 1,243.09 201.73 607.03 1,020.82

Sunflower Pharmaceutical Group Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,073 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunflower Pharmaceutical Group Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunflower Pharmaceutical Group Co (SZSE:002737) Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.

Sunflower Pharmaceutical Group Co (SZSE:002737) Headlines

No Headlines